Speedy US review for MSD’s Keytruda in cervical cancer
admin 14th March 2018 Uncategorised 0US regulators will undertake a priority review of MSD’s Keytruda as a treatment for patients with advanced cervical cancer.
More: Speedy US review for MSD’s Keytruda in cervical cancer
Source: News